Great post. I agree with you 100 percent. My recent frustration was derived from getting to bullish and my expectations getting out of hand. I was wrong, but I still think we have a legitimate chance to FDA approval and a triple. There recent price action is frustrating and I suspect a capital infusion via a loan sooner rather than later. However, a loan infusion to grow the biz because they are actually increasing international is bullish and should not be sold. Cartwright is a positive but the company has a long history of failure dealing with the FDA. Hoping new consultant helps me navigate the FDA and we get great news this summer. I am betting on the technology despite the mgmt team.we have erased almost all the gains from the Cartwright announcement.
Why sale at these levels? like wawallace I am going to hold to my shares. I got too bullish on the stock and I regret it. However, I think we have a legitimate chance at getting FDA approval and the shares might rebound to $1.50. Short term it looks ugly. Hoping/waiting for announcement that might change the current trend.
I have reached the same conclusion. I only have 120K shares. There is no point fighting it. Hoping it pays off in the future.
Down on heavy volume is always a concern. It seems a large market order (why?) took GTHP down to 45.5 cents. Why would you place a market order for so many shares? I am disappointed by the lack of news flow and concerned about a capital raise but selling at these levels? Why sale? I am going to hold until I hear from FDA.
I hope you are right.... We need good company news to move. I guess March 26th?
The person buying at 53 cents got all the shares he/she wanted. Opened at 55 cents for a split second then 40K shares sold at 53 cents until they destroyed the bid. Bid back to 52 cents. Dead money until we get news.
This the reason GTHP does not have time to waste. If they do not execute all the potential will vanish sooner rather than later. Hoping for a progress report in March 26 that is positive for a change.
Do not bring historical facts to his attention.... You are going to make gmeabrk mad! We will get another long tirade about nagging women and such.... Gmeabrk's boyfriend needs to get a control of the situation.
You have a really negative view of women. You are constantly comparing negative comments to the way you perceive a woman to behave, act or talk. Maybe they behave is such a way around you because of your righteous than hell attitude? Do you need to get out of the closet?
You need to recognize that GTHP has a long history of failure. That is a fact. They have a great opportunity with Luviva and the technology. Good step forward with Cartwright. However, at this point, is very valid to raise questions about GTHP since the management has failed to get FDA approval for the last two years and continues to raise capital while international sales are not ramping up yet. In my opinion, the management could and should do more to support the stock unless of course there is no good news to report.
At the end of the day I think you rather spent the day (and night) with Mr. Cartwright than any hot woman. I guess we all have our preferences. Maybe you should be more open to discussion about other views.
I was also looking at GTHP with pink colored glasses at the time instead of fully understanding GTHP repeated histories of failures. The only think they do well is raise capital.
Holy, unfounded? Please correct me. How many times has GTHP failed to get approval for Luviva? I believe the number is 2. This will be the third time the company will try to get approval. So..... I can honestly say the company has no clue how to navigate the FDA. During the last 2 years and their 2 failures to get approval for Luviva how many capital raises? Just last year they did a secondary in the Spring and sold warrants in the fall. Again ZERO execution. Please correct any of the facts.
As far as Cartwright, he is new and needs time.... However due to the serial failures by GTHP he does not have much time in my opinion. Hey how about another capital raise? Maybe they hired cartwright just to justify raising money again.
The stock is cheap at these levels, but what is the catalyst that will make investors buy this stock? Can anyone trust this (mis) management team? The mis (management) team has a loooooooong history of failures. Unable to navigate the FDA and unable to get approval now twice for Luviva. I was glad to see Cartwright come in as CEO, but I am yet to see one action by this man to justify his pay. Despite (mis) management inability to get FDA approval they are approved in several countries. However, where are the sales? International ramp up? When?????? Sexy technology but zero execution. The only thing this company does promptly is to raise capital. If you do your DD and fall in love with the product be warned of GTHP's management team. ZERO execution again and again. It is time for GTHP to show sales, discuss meetings with FDA, etc... but i am sure their priority is probably raising more capital so we can pay for Cartwright. DO SOMETHING FOR THE SHAREHOLDER for a change.
Horrible management team unable to properly navigate the FDA. GTHP has a long history of failure. Great technology but zero execution. They are only good at raising capital.
I plan to hold.... Completely disgusted with my GTHP position but I am trapped. GTHP history of failures and horrible mgmt seems to continue.
We are not going to get any help from mgmt today either. I hope they remember to show up to the conference call on march 26th.... unless (mis)management is too busy looking to raise capital to pay their salaries.
It seems the beatings will continue until morale improves. At least the selling is with low volume. More of a buyers strike? Maybe the company can give the market a reason to buy soon. That would be nice for a change.